[Genetic aspects of cardiac conduction defects].

Vincent Probst(Centre National de la Recherche Scientifique), Hervé Le Marec(Centre National de la Recherche Scientifique), Jean‐Jacques Schott(Centre National de la Recherche Scientifique), Florence Kyndt(Inserm), Marie Allouis(Inserm)

PubMed

November 1, 2003

Cited by 4

Related Papers

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

|Heart Rhythm|2011|1.5k

Congenital Heart Disease Caused by Mutations in the Transcription Factor <i>NKX2-5</i>

|Science|1998|1.3k

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

|Nature|2003|961

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)

|EP Europace|2011|904

Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome

|Circulation|2010|850